Atazanavir
Mostrando 13-18 de 18 artigos, teses e dissertações.
-
13. Avaliação in vitro da atividade antiviral de produtos sintéticos e naturais contra lentivírus de pequenos ruminantes. / In vitro evaluation of antiviral activity of synthetic and natural products against small ruminant lentiviruses.
Objetivou-se avaliar o efeito antiviral de produtos sintéticos e naturais em fibroblastos caprinos infectados pelos vírus da Artrite Encefalite Caprina (CAEV) cepa Cork e Maedi-Visna (MVV) cepa K1514. Foram utilizados os inibidores da transcriptase reversa: lamivudina, zidovudina, didanosina, estavudina e efavirenz; os inibidores da protease lopinavir/rito
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 15/12/2008
-
14. Dyslipidaemia associated with the highly active antiretroviral therapy in aids patient: reversion after switching (stavudine to tenofovir and lopinavir/ritonavir to atazanavir/ritonavir)
Antiretroviral therapy has been associated with hyperlipidemia in AIDS patients. This case illustrates the classic metabolic effects associated to the HAART including protease inhibitors and/or stavudine. It was showed that the management of the HAART-associated dyslipidaemia with conventional antihyperlipidemic therapy may fail, being the switching strategy
Brazilian Journal of Infectious Diseases. Publicado em: 2007-04
-
15. Efeitos metabólicos associados à terapia anti-retroviral potente em pacientes com Aids
Este estudo teve como objetivo avaliar as anormalidades metabólicas - dislipidemia , resistência à insulina e lipodistrofia que constituem a Síndrome Lipodistrófica, associada à terapia anti-retroviral potente (HAART) em pacientes com a Síndrome da Imunodeficiência Adquirida (AIDS) tratados em Campo Grande, Mato Grosso do Sul, Brasil. Inicialmente, p
Publicado em: 2006
-
16. Activities of Atazanavir (BMS-232632) against a Large Panel of Human Immunodeficiency Virus Type 1 Clinical Isolates Resistant to One or More Approved Protease Inhibitors
To evaluate the cross-resistance profile of the human immunodeficiency virus type 1 protease inhibitor (PI) atazanavir (BMS-232632), a panel of 551 clinical isolates exhibiting a wide array of PI resistance profiles and a variety of genotypic patterns were assayed for susceptibility to atazanavir and six other PIs: amprenavir, indinavir, lopinavir, nelfinavi
American Society for Microbiology.
-
17. Interactions between Atazanavir-Ritonavir and Tenofovir in Heavily Pretreated Human Immunodeficiency Virus-Infected Patients
The aim of the present study was to assess the pharmacokinetic behavior of atazanavir-ritonavir when it is coadministered with tenofovir disoproxil fumarate (DF) in human immunodeficiency virus (HIV)-infected patients. Eleven patients enrolled in Agence Nationale de Recherche sur le SIDA (National Agency for AIDS Research, Paris, France) trial 107 were inclu
American Society for Microbiology.
-
18. Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors
Oxford University Press.